Endothelial dysfunction late after Kawasaki disease

Circulation

Volumn 94, Issue 9, 1996, Pages 2103-2106

  Dhillon, Rami ^b   Clarkson, Peter ^b   Donald, Ann E ^b   Powe, Amanda J ^b   Nash, Margot ^a   Novelli, Vas ^a   Dillon, Michael J ^a   Deanfield, John E ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b Children NHS Trust ^*

Author keywords

Kawasaki disease; ultrasonics

Indexed keywords

ADOLESCENT; ARTICLE; BRACHIAL ARTERY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART INFARCTION; HUMAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUDDEN DEATH; VASCULAR ENDOTHELIUM;

EID: 0029828036     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.9.2103     Document Type: Article

References (29)

1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa S. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics. 1974;54:271-276.
2. Kato H, Ichinose E, Kawasaki T. Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases. J Pediatr. 1986;108:923-927.
3. Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, Gerber M, Shulman ST, Karchmer AW, Wilson W, Peter G, Durack DT, Rahimtoola SH. Guidelines for long-term management of patients with Kawasaki disease. Circulation. 1994;89:916-922.
4. Sugimura T, Kato H, Inoue O, Takagi J, Fukuda T, Sato N. Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. J Pediatr. 1992;121:684-688.
5. Kato H, Inoue O, Kawasaki T, Fujiwara H, Watanabe T, Toshima H. Adult coronary artery disease probably due to childhood Kawasaki disease. Lancet. 1992;340:1127-1129.
6. Naoe S, Shibuya K, Takahashi K, Wakayama M, Masuda H, Tanaka N. Pathological observations concerning the cardiovascular lesions in Kawasaki disease. Cardiol Young. 1991;1:212-220.
7. Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferried P, Freed M, Takahashi M, Bierman FZ, Karchmer AW, Wilson W, Rahimtoola SH, Durak DT, Peter G. Diagnosis and therapy of Kawasaki disease in children. Circulation. 1993;87:1776-1780.
8. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
9. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, Deanfield JE. Non-invasive measurement of endothelium-dependent arterial responses in man: accuracy and reproducibility. Br Heart J. 1995;74:247-253.
10. Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 1975;86:892-898.
11. Suzuki A, Kamiya T, Kuhawara N, Ono Y, Kohata T, Takahashi O, Kimura K, Takamiya M. Coronary arterial lesions of Kawasaki disease: cardiac catheterization findings of 1100 cases. Pediatr Cardiol. 1986;7:3-9.
12. Kato H, Ichinose E, Yoshioka F, Takechi T, Matsunaga S, Suzuki K, Rikitake N. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am J Cardiol. 1982;49:1758-1766.
13. Agaki T, Rose V, Benson LN, Newman A, Freedom RM. Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr. 1992;121:689-694.
14. Hirose S, Hamashima Y. Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. Eur J Pediatr. 1978;129:17-27.
15. Fujiwara H, Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics. 1978;61:100-107.
16. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;8:488-500.
17. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
18. Cooke JP, Tsao PS. Is NO an anti-atherogenic molecule? Arterioscler Thromb. 1994;14:653-655.
19. Rubanyi GM, Romero C, Vanhouette PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 1986;250:H1115-H1119.
20. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C, Luscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995;91:1314-1319.
21. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager MA, Yeung AC, Selwyn AP. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 1995;26: 1235-1241.
22. Georgakopoulos D, Celermajer DS, Thomas O, Robinson J, Betteridge DJ, Deanfield JE. Endothelium dependent dilatation is impaired in the large arteries of healthy young adults with type I diabetes and is related to the presence of microalbuminuria. J Am Coll Cardiol. 1994;23:426A. Abstract.
23. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88(pt 1):2149-2155.
24. Sorensen K, Celermajer D, Georgakopoulos D, Hatcher G, Betteridge J, Deanfield J. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein (a) level. J Clin Invest. 1994;93:50-55.
25. Newburger JW, Burns JC, Beiser AS, Loscalzo J. Altered lipid profile after Kawasaki syndrome. Circulation. 1991;84:625-631.
26. Anderson KM, Castelli WP, Levy DL. Cholesterol and mortality: 30 years of follow-up from the Framingham study. JAMA. 1987;257: 2176-2180.
27. Shulman ST, Bass JL, Bierman F, Burns JC, Chung K, Dillon MJ, Duffy E, Fulton D, Gersony WM, Gidding S, Gillespie SM, Glode MP, Koren G, Lehman TJA, Mason WH, Meissner C, Melish ME, Neches WH, Newburger JW, Rose V, Rowley AH, Silverman E, Takahashi M. Management of Kawasaki syndrome: a consensus statement prepared by North American participants of the Third International Kawasaki Disease Symposium, Tokyo, Japan, December 1988. Pediatr Infect Dis J. 1989;8:663-667.
28. Cooke JP, Singer AH, Tsao P, Sera P, Rowan RA, Billingham ME. Anti-atherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
29. Loscalzo J. Nitric oxide and vascular disease. N Engl J Med. 1995; 333:251-253.